Xtl Biopharmaceuticals (XTLB) Common Equity (2009 - 2025)
Xtl Biopharmaceuticals' Common Equity came in at -$254,000 for the quarter ended Dec 31, 2025, compared with $5.44 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Common Equity (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Common Equity data covers 66 quarters.
- Going back by year, Common Equity was $5.44 million in the year ended Dec 31, 2024 (+144.8%), $2.22 million in the year ended Dec 31, 2023 (-44.5%), $4 million in the year ended Dec 31, 2022 (-25.0%) and $5.33 million in the year ended Dec 31, 2021 (+47.6%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Common Equity since the quarter ended Jun 30, 2010.
- Year-over-year, Common Equity increased in two of the last four quarters, with growth averaging 60.8%.
- The fastest year-over-year change in Common Equity over five years came in the quarter ended Dec 31, 2024 (growth of 144.8%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 51.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | -254,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -254,000.00 |
| Jun 30, 2025 | -47,000.00 |
| Dec 31, 2024 | 5.44 Mn |
| Sep 30, 2024 | 5.72 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.74 Mn |
| Jun 30, 2022 | 5.56 Mn |
| Mar 31, 2022 | 5.84 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | 3.28 Mn |
| Mar 31, 2021 | 4.37 Mn |
| Dec 31, 2020 | 3.61 Mn |
| Sep 30, 2020 | 6.03 Mn |
API Access
Xtl Biopharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();